Amarin Corporation plc (AMRN)
NasdaqGM - NasdaqGM 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 0.8601 |
| 開市 | 0.8726 |
| 買盤 | 0.8672 x 400 |
| 賣出價 | 0.8766 x 200 |
| 今日波幅 | 0.8610 - 0.8798 |
| 52 週波幅 | 0.6500 - 1.4900 |
| 成交量 | |
| 平均成交量 | 1,602,990 |
| 市值 | 351.146M |
| Beta 值 (5 年，每月) | 2.01 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.1500 |
| 業績公佈日 | 2024年5月01日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 1.08 |
ZacksAmarin (AMRN) Up 7% on Intellectual Property Wins in Europe
Amarin (AMRN) secures a new patent for Vazkepa in Europe, which extends its exclusivity for eight more years. It achieves success in defending another patent on the drug against third parties.
Motley FoolWhy Amarin Stock Was Rocketing Higher on Wednesday
There was unambigously good news about the company's single commercialized medication.
- Zacks
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
Amarin's (AMRN) fourth-quarter 2023 earnings and revenues beat estimates. Vascepa's sales in the United States decline year over year.
